IRIS
Lanzafame, Massimiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.230
AS - Asia 1.435
EU - Europa 888
Continente sconosciuto - Info sul continente non disponibili 341
SA - Sud America 331
AF - Africa 58
OC - Oceania 16
Totale 5.299
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.137
IT - Italia 498
SG - Singapore 446
VN - Vietnam 284
CN - Cina 271
BR - Brasile 261
KR - Corea 166
DE - Germania 70
FR - Francia 70
NL - Olanda 64
BD - Bangladesh 49
FI - Finlandia 46
GB - Regno Unito 43
HK - Hong Kong 43
IN - India 43
CA - Canada 42
MX - Messico 30
ZA - Sudafrica 27
AR - Argentina 22
IQ - Iraq 20
PK - Pakistan 20
LV - Lettonia 17
EC - Ecuador 15
JP - Giappone 15
TR - Turchia 15
PL - Polonia 14
AU - Australia 13
ID - Indonesia 13
RU - Federazione Russa 12
MA - Marocco 11
ES - Italia 9
IE - Irlanda 9
SA - Arabia Saudita 9
SE - Svezia 8
AT - Austria 7
PE - Perù 7
UA - Ucraina 7
VE - Venezuela 7
CO - Colombia 6
JO - Giordania 6
PH - Filippine 6
CR - Costa Rica 5
EG - Egitto 5
MY - Malesia 5
PY - Paraguay 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
UY - Uruguay 4
UZ - Uzbekistan 4
CL - Cile 3
JM - Giamaica 3
KE - Kenya 3
NZ - Nuova Zelanda 3
BF - Burkina Faso 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IL - Israele 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
SI - Slovenia 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
BE - Belgio 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
ML - Mali 1
MN - Mongolia 1
MW - Malawi 1
NG - Nigeria 1
PA - Panama 1
QA - Qatar 1
SN - Senegal 1
ST - Sao Tome e Principe 1
SV - El Salvador 1
TW - Taiwan 1
VG - Isole Vergini Britanniche 1
Totale 4.958
Salva come PNG Salva come JPEG
Città #
San Jose 323
Dallas 314
Singapore 263
Ashburn 232
Council Bluffs 190
Seoul 165
Trento 99
Ho Chi Minh City 93
Columbus 81
Los Angeles 77
Chicago 58
Hanoi 58
Beijing 49
Lauterbourg 43
Amsterdam 40
New York 40
Hong Kong 39
Rome 38
Helsinki 37
Milan 37
Munich 35
Santa Clara 30
São Paulo 30
Orem 28
Boardman 27
Buffalo 26
Denver 25
Salt Lake City 24
Johannesburg 21
St Louis 19
Cavalese 17
Da Nang 17
Riga 17
Atlanta 15
Mexico City 15
Cornedo Vicentino 14
Jinan 14
Naples 14
Phoenix 13
Redondo Beach 13
Tokyo 13
Haiphong 12
Houston 12
Marcianise 12
Warsaw 12
Karachi 11
London 11
Miano 11
Montreal 11
Tampa 11
Chennai 10
Elk Grove Village 9
Guangzhou 9
Manchester 9
Padua 9
Terrasini 9
Verona 9
Baghdad 8
Brooklyn 8
Clifton 8
Frankfurt am Main 8
Mumbai 8
North Bergen 8
Philadelphia 8
Ankara 7
Miami 7
Rio de Janeiro 7
San Francisco 7
Boston 6
Brasília 6
City of London 6
Dublin 6
Lancaster 6
Pescara 6
Riyadh 6
Toronto 6
Ziano di Fiemme 6
Belo Horizonte 5
Cairo 5
Canoas 5
Charlotte 5
Detroit 5
Hải Dương 5
Istanbul 5
Kansas City 5
Lahore 5
Nuremberg 5
Salvador 5
Seattle 5
Shanghai 5
Stockholm 5
Turin 5
Amman 4
Can Tho 4
Curitiba 4
Dhaka 4
Falkenstein 4
Hefei 4
Hillsboro 4
Memphis 4
Totale 3.115
Salva come PNG Salva come JPEG
Nome #
Meningite da Escherichia Coli in una persona con infezione da HIV; descrizione di un caso clinico e revisione della letteratura = Escherichia Coli meningitis in a person living with HIV infection: a clinical case and review of the literature. 200
Antibiotic Resistance Patterns Among Uropathogens in Female Outpatients Affected by Uncomplicated Cystitis: Focus on Fosfomycin Trometamol 158
A Precision Medicine Model for Targeted Antibiotic Therapy in Urinary Tract Infections: A Valuable Tool to Reduce Hospitalization Stay and the Time to Switch to Oral Treatment 137
Advances in HIV Treatment: Long-Acting Antiretrovirals and the Path Toward a Cure 102
'High' antiretroviral deintensification strategy and cellular HIV DNA levels 100
Mini-review: Silico-tuberculosis 100
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 96
Uso degli antibiotici nel fine vita 92
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 92
Breastfeeding in women living with HIV in high-income countries: It's time to act 92
A multicentre real-life prospective cohort study on effectiveness, durability and safety of long-acting injectable cabotegravir and rilpivirine in northern Italy: the LONGITUDE study 89
When an underestimated zoonosis and antimicrobial resistance collide: Corynebacterium ulcerans 85
Bridging the gap in bloodstream infection management: a survey among non-infectious disease physicians 84
Benign acute viral myositis in African migrants: a clinical, serological and pathological study 84
Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID-IRI study 79
Rezafungin Utilisation in Real Life—FungiScope Results From Europe and the United States 76
Profiles of primary brain abscesses and their impact on survival: An international ID-IRI study 75
Computational characterization of peptide binding stability to HLA-C allotypes and its association with HIV-1 infection progression and HIV-1 related neurocognitive impairment. 72
Recurrent UTI: Questions and Answers on Clinical Practice 71
Primary cutaneous cryptococcosis in a HIV infested patient: case report 70
Treatment of Candida glabrata native valve endocarditis with rezafungin: a case report 69
Emerging strategies in tackling antimicrobial resistance in urology: Narrative review and expert opinion 69
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 67
Acceptability of Switching to Long-Acting Cabotegravir and Rilpivirine Among People Living with HIV on Dolutegravir/Rilpivirine Combination: A Single-Center Experience 65
HIV screening of migrants in the autonomous Province of Trento (North-Eastern Italy) 62
Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study 62
The diagnostic yield of the Meares & Stamey test can be significantly improved by symptom-based patient selection and the experience of the test performer 60
Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and Hepatitis B and C-infected patients treated with ART 59
High malaria parasitemia in an Italian man and severe delayed hemolytic anemia 59
Is monoclonal antibody administration necessary in all vaccinated patients with breakthrough COVID-19 infections? 58
"High" antiretroviral deintensification, a strategy to avoid drug interactions and unfavourable long-term effects of HAART 57
“Terapia intermittente” con bictegravir/emtricitabina/tenofovir alafenamide in una piccola coorte di pazienti con infezione da HIV, virologicamente soppressi = Short cycle therapy with bictegravir/emtricitabine/tenofovir alafenamide in a small cohort of virally suppressed people living with HIV. 55
WISE (Web-based Infectious Support for the Elderly) Initiative: Improving Infectious Disease Management in LTCFs―Experience From Northern Italy 53
Adherence to HAART in HIV 52
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study 52
Klebsiella pneumoniae resistant to carbapenems: bloodstream infection prevalence before and during the SARS-CoV-2 pandemic in a tertiary level, North-Eastern Italian Hospital 51
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report 51
Behavioural and demographic correlates of undiagnosed HIV infection in a MSM sample recruited in 13 European cities 50
. Raltegravir plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-positive Patients: Safety, Efficacy and Pharmacokinetics 49
Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report 47
Short-cycle therapy (5 days on/2 days off) with a lamivudine + dolutegravir regimen in a cohort of virologically suppressed patients with HIV infection 46
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 46
A reduced dose of darunavir/ritonavir is effective in PI-experienced HIV-infected patients 45
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 43
Rapid radiological improvement of COVID-19 pneumonia after treatment with tocilizumab 42
A Maintenance Dose of Atazanavir/Ritonavir 200/100 mg Once Daily Is Effective in Virologically Suppressed HIV-1–Infected Patients 41
Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study 41
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients 40
Short-Cycle Therapy with Bictegravir/Emtricitabine/Tenofovir Alafenamide in a Small Cohort of Virally Suppressed People Living with HIV: A Long-Term Follow-Up 39
Simplification to dual-therapy containing lamivudine and darunavir/ritonavir or atazanavir/ritonavir in HIV-infected patients on virologically suppressive antiretroviral therapy 38
The burden and epidemiology of community-acquired central nervous system infections: a multinational study 37
Aetiology of pneumonia following isolated closed head iniury 36
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona) 36
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation 35
Antiretroviral therapy in low-resource settings 35
HIV-1-associated neurocognitive disorders: is HLA-C binding stability to β2-microglobulin a missing piece of the pathogenetic puzzle? 34
Cardiovascular Drug Interactions with Nirmatrelvir/Ritonavir for COVID-19: Considerations for Daily Practice. 33
Antiretroviral therapy-associated diseases are common in the long-term 33
Influenza dell’attività fisica sul valore ematico dei lipidi in una piccola coorte di pazienti che vivono con infezione da HIV, soppressi e dislipidemici, dopo lo switch da un regime contenente tenofovir alafenamide a dolutegravir/rilpivirina = Influence of physical activity level on serum lipid values in a small cohort of suppressed dyslipidemic people living with HIV after switching from a tenofovir alafenamide regimen to dolutegravir/rilpivirine. 33
HIV and SARS-Coronavirus-2 Epidemics: Possible Interactions and Need for Studies, Especially in Africa 33
HIV treatment default in sub-Saharan Africa: issues and possible solutions 32
Features of Mpox infection: The analysis of the data submitted to the ID-IRI network 32
HIV-1 RNA levels in semen of people on 'short-cycle' antiretroviral therapy 31
Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients 31
Patient-centered Care and Treatment in HIV Infection 31
HIV serostatus knowledge and serostatus disclosure with the most recent anal intercourse partner in a European MSM sample recruited in 13 cities: results from the Sialon-II study 31
Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up 31
Letter to the Editor: Dolutegravir Monotherapy and Body Weight Gain in Antiretroviral Naïve Patients 31
Disseminated Mycobacterium chimaera infection after open heart surgery in an Italian woman: a case report and a review of the literature 30
Socio-demographic Characteristics, Sexual and Test-Seeking Behaviours Amongst Men Who have Sex with Both Men and Women: Results from a Bio-behavioural Survey in 13 European Cities 27
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 27
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 27
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 27
The treatment of latent TB infection in HIV-positive people: the Verona experience 25
Successful Antifungal Combination Therapy and Surgical Approach for Aspergillus fumigatus Suppurative Thyroiditis Associated with Thyrotoxicosis and Review of Published Reports 25
Short Cycle, Intermittent Therapy: A Valuable Option in Selected, Virologically Suppressed People Living with HIV 24
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials 24
Tuberculosis-immune reconstitution inflammatory syndrome 24
Community acquired bacteremia In older adults: International and prospective infectious diseases-international research initiative (ID-IRI) study 23
DRIVE-AHEAD Trial's Results and the Need for a More Appropriate Comparator Drug 22
Dolutegravir monotherapy: an option for highly adherent HIV1-infected naive patients with relatively low zenith HIV-RNA? 22
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life 22
Successful Treatment of Castleman's Disease with HAART in two HIV-infected patients. 21
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 21
Mycobacterium chimaera infections following cardiac surgery in Italy: results from a National Survey Endorsed by the Italian Society of Cardiac Surgery 20
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study) 19
HIV infection should no longer be detected at late stages in Italy 19
Optimal fosamprenavir regimen to prevent lipid abnormalities. 18
Efavirenz dose reduction in HIV-infected patients 18
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings 18
Is there a role for TNF-alpha in HIV1-associated lipodystrophy? 17
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load 17
Factors affecting inflammatory markers in neutropenic patients with bacteremia: An international ID-IRI study 17
Dolutegravir Monotherapy's Virological Efficacy in a Highly Treatment-Experienced Patient 17
La riduzione del dosaggio giornaliero di efavirenz nella terapia antiretrovirale: impatto sul budget nell’Azienda Ospedaliera Universitaria Integrata di Verona 16
Chagas disease in Italy: breaking an epidemiological silence 16
Voluntary or Universal HIV testing in Italy? 15
Long-acting injectable cabotegravir/rilpivirine in a pregnant woman living with HIV with hyperemesis gravidarum:a case report and review of literature 15
Cutaneous abscess due to Eubacterium lentum in injection drug user: a case report and review of the literature 15
The ParaSight-F rapid dipstick antigen capture assay for monitoring parasite clearance after drug treatment of Plasmodium Falciparum malaria 15
Totale 4.780
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.772
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025302 0 0 0 0 0 0 0 0 1 179 34 88
2025/20264.469 113 157 585 599 621 274 322 220 517 679 190 192
2026/2027528 248 280 0 0 0 0 0 0 0 0 0 0
Totale 5.299